SCHEDULE: Point72 Discloses Negligible KALA BIO Stake

Point72 Asset Management, along with Point72 Capital Advisors Inc. and Steven A. Cohen, reported a 0.0% beneficial ownership in KALA BIO, Inc. as of September 30, 2025.

Summary

• Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen collectively reported beneficial ownership of 257 shares of KALA BIO, Inc. common stock.
• This ownership represents 0.0% of the class of KALA BIO, Inc. common stock.
• The reporting persons, including Point72 Asset Management, Point72 Capital Advisors Inc., and Steven A. Cohen, share voting and dispositive power over these 257 shares.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating a previous filing existed.
• The shares were not acquired or held for the purpose of changing or influencing control of KALA BIO, Inc.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of a negligible ownership stake (0.0%) and contains no material information that would significantly alter the perception of the company's financial health or prospects. It is purely a factual reporting of a minor investment position.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of beneficial ownership by an institutional investor, Point72 Asset Management, in a publicly traded biotechnology company, KALA BIO, Inc. Such filings are common and provide transparency regarding significant holdings, though in this case, the reported stake is negligible.

Stakeholder Impact

• Shareholders: The disclosure of a 0.0% stake by Point72 Asset Management is unlikely to have any material impact on existing shareholders, as it does not signal a significant investment or divestment strategy.

Key Dates

Keywords

KALA BIO, Point72 Asset Management, Steven A. Cohen, Schedule 13G, Beneficial Ownership, Common Stock, Investment Fund